Switzerland is one of the most reputable and innovative biotech hubs in the world. Local companies hold leading positions throughout many sectors and thus attract capital, partnerships and talents from all regions. The basis for this success is a close-knit network between research and development, driven by renowned universities, highly-specialized SMEs and strong multinational corporations.
KPMG’s site selection report 2018 for life sciences companies in Europe compares the attractiveness of different countries. It clearly shows that the Swiss biotech hub is leading by many accounts.